Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

United Therapeutics (UTHR) Inventory Average (2016 - 2025)

Historic Inventory Average for United Therapeutics (UTHR) over the last 16 years, with Q3 2025 value amounting to $172.8 million.

  • United Therapeutics' Inventory Average rose 2206.92% to $172.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $172.8 million, marking a year-over-year increase of 2206.92%. This contributed to the annual value of $134.8 million for FY2024, which is 2614.59% up from last year.
  • United Therapeutics' Inventory Average amounted to $172.8 million in Q3 2025, which was up 2206.92% from $167.3 million recorded in Q2 2025.
  • Over the past 5 years, United Therapeutics' Inventory Average peaked at $172.8 million during Q3 2025, and registered a low of $89.0 million during Q2 2022.
  • Moreover, its 5-year median value for Inventory Average was $102.9 million (2023), whereas its average is $115.4 million.
  • Per our database at Business Quant, United Therapeutics' Inventory Average tumbled by 361.38% in 2021 and then skyrocketed by 4095.33% in 2024.
  • United Therapeutics' Inventory Average (Quarter) stood at $95.2 million in 2021, then grew by 1.31% to $96.5 million in 2022, then grew by 11.97% to $108.0 million in 2023, then soared by 40.95% to $152.3 million in 2024, then grew by 13.49% to $172.8 million in 2025.
  • Its Inventory Average stands at $172.8 million for Q3 2025, versus $167.3 million for Q2 2025 and $161.6 million for Q1 2025.